Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

CUSIP: 86366E106

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Ordinary Shares, par value $0.0001 per share
Shares outstanding
213,001,347
Total 13F shares
42,586,066
Share change
+9,722,259
Total reported value
$1,736,374,072
Put/Call ratio
15%
Price per share
$40.76
Number of holders
121
Value change
+$365,354,803
Number of buys
83
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 86366E106?
CUSIP 86366E106 identifies GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.2%
2,513,563
$126,734,000 30 Sep 2023
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.1%
2,388,876
$120,447,128 30 Sep 2023
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.98%
2,091,323
$97,499,156 30 Sep 2023
13F
Deep Track Capital, LP
13F
Company
0.9%
1,915,000
$96,554,300 30 Sep 2023
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.85%
1,799,923
$90,752,118 30 Sep 2023
13F
BVF INC/IL
13F
Company
0.82%
1,750,000
$88,235,000 30 Sep 2023
13F
FMR LLC
13F
Company
0.75%
1,590,335
$80,184,691 30 Sep 2023
13F
T. Rowe Price Investment Management, Inc.
13F
Company
0.74%
1,571,677
$79,244,000 30 Sep 2023
13F
TCG Crossover Management, LLC
13F
Company
0.71%
1,502,747
$75,768,504 30 Sep 2023
13F
Casdin Capital, LLC
13F
Company
0.59%
1,258,166
$61,956,632 30 Sep 2023
13F
FEDERATED HERMES, INC.
13F
Company
0.52%
1,110,200
$55,976,284 30 Sep 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.51%
1,080,592
$54,483,449 30 Sep 2023
13F
HSG Holding Ltd
13F
Company
0.5%
1,065,226
$53,708,695 30 Sep 2023
13F
Cormorant Asset Management, LP
13F
Company
0.5%
1,056,373
$53,262,327 30 Sep 2023
13F
Avoro Capital Advisors LLC
13F
Company
0.47%
1,000,000
$50,420,000 30 Sep 2023
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.41%
867,579
$43,743,333 30 Sep 2023
13F
Point72 Asset Management, L.P.
13F
Company
0.35%
747,100
$37,668,782 30 Sep 2023
13F
Monashee Investment Management LLC
13F
Company
0.3%
633,766
$31,954,482 30 Sep 2023
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.29%
627,813
$31,654,331 30 Sep 2023
13F
BlackRock Finance, Inc.
13F
Company
0.25%
527,330
$26,587,979 30 Sep 2023
13F
Avidity Partners Management LP
13F
Company
0.23%
500,000
$25,210,000 30 Sep 2023
13F
Logos Global Management LP
13F
Company
0.23%
500,000
$25,210,000 30 Sep 2023
13F
JENNISON ASSOCIATES LLC
13F
Company
0.2%
420,479
$21,200,551 30 Sep 2023
13F
First Light Asset Management, LLC
13F
Company
0.18%
374,412
$18,877,853 30 Sep 2023
13F
Capital Research Global Investors
13F
Company
0.16%
344,848
$17,262,125 30 Sep 2023
13F
Ramy Farid
3/4/5
Director
mixed-class rows
3,535,495
mixed-class rows
$17,176,500 07 Feb 2023
MILLENNIUM MANAGEMENT LLC
13F
Company
0.14%
299,874
$15,119,647 30 Sep 2023
13F
Holocene Advisors, LP
13F
Company
0.13%
281,291
$14,182,692 30 Sep 2023
13F
FRANKLIN RESOURCES INC
13F
Company
0.12%
250,820
$12,646,344 30 Sep 2023
13F
MPM BioImpact LLC
13F
Company
0.11%
230,761
$11,634,970 30 Sep 2023
13F
Sofinnova Investments, Inc.
13F
Company
0.09%
202,119
$10,190,840 30 Sep 2023
13F
Woodline Partners LP
13F
Company
0.08%
170,000
$8,571,400 30 Sep 2023
13F
Altium Capital Management LLC
13F
Company
0.07%
155,000
$7,815,100 30 Sep 2023
13F
TD ASSET MANAGEMENT INC
13F
Company
0.07%
152,176
$7,672,714 30 Sep 2023
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.07%
150,958
$7,611,302 30 Sep 2023
13F
Ikarian Capital, LLC
13F
Company
0.06%
137,824
$6,949,086 30 Sep 2023
13F
GMT CAPITAL CORP
13F
Company
0.05%
113,200
$5,707,544 30 Sep 2023
13F
Invesco Ltd.
13F
Company
0.05%
113,093
$5,702,149 30 Sep 2023
13F
MARSHALL WACE, LLP
13F
Company
0.05%
107,518
$5,421,058 30 Sep 2023
13F
Capital World Investors
13F
Company
0.05%
100,400
$5,025,743 30 Sep 2023
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.05%
99,340
$5,008,723 30 Sep 2023
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.04%
86,474
$4,360,019 30 Sep 2023
13F
HighVista Strategies LLC
13F
Company
0.04%
74,832
$3,773,029 30 Sep 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.03%
71,433
$3,601,652 30 Sep 2023
13F
WEXFORD CAPITAL LP
13F
Company
0.03%
67,978
$3,427,451 30 Sep 2023
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.03%
55,086
$2,777,436 30 Sep 2023
13F
Ghost Tree Capital, LLC
13F
Company
0.03%
55,000
$2,773,100 30 Sep 2023
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.02%
52,461
$2,645,084 30 Sep 2023
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.02%
50,000
$2,521,000 30 Sep 2023
13F
Informed Momentum Co LLC
13F
Company
0.02%
43,978
$2,217,371 30 Sep 2023
13F

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q4 2023

As of 31 Dec 2023, Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,586,066 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Avoro Capital Advisors LLC, FEDERATED HERMES, INC., TCG Crossover Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, and T. Rowe Price Investment Management, Inc.. This page lists 121 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
83
Q4 2023 holders
121
Holder diff
38
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.